Sumitomo Dainippon publishes positive results of schizophrenia drug
Japanese pharma company Sumitomo Dainippon has announced its drug Lonasen (blonanserin) has achieved its primary endpoint in a Phase III...
Focus:
-
![Sarcoma Awareness Month: innovative treatments for a ‘forgotten cancer’]()
Sarcoma Awareness Month: innovative treatments for a ‘forgotten cancer’
-
![Researchers develop ‘Trojan horse’ chemo drug delivery system]()
Researchers develop ‘Trojan horse’ chemo drug delivery system
-
![Gotham and Mercachem generate epitranscriptomic target library]()
Gotham and Mercachem generate epitranscriptomic target library
-
![AM-Pharma raises €116m to support SA-AKI Phase III trial]()
AM-Pharma raises €116m to support SA-AKI Phase III trial
-
![US opioid crisis: charting Insys’ fall from grace]()
US opioid crisis: charting Insys’ fall from grace
-
![Boehringer acquires AMAL Therapeutics for $366m]()
Boehringer acquires AMAL Therapeutics for $366m
Expert commentary & analysis from GlobalData
KRAS-targeting therapies’ differences in solid tumours may be clinically irrelevant
Sage’s Zulresso for postpartum depression has uncertain payer coverage
AZ’s Forxiga earns EU CHMP recommendation for inclusion of cardiovascular outcomes
Pregnancy outcomes in women with lupus significantly improved in the last 18 years
Most Read
Company releases
Sepha Multi-Q – Overview
Learn About the GMP Standard for OTC Drug Manufacture
NSF’s Laurence Matheron and Robyn Meurant Participate in MedFIT Panels in Lille, France
Two NSF medical device experts took part in panel discussions on June 25 at the MedFIT conference in Lille, France.
Broadening Biopharmaceutical Supply Chain Capacity Using Drones
Smooth and Automatically Sampling with a HECHT Sampling Carousel
HECHT has announced the release of a new sample carousel. First released earlier this year,...
Company whitepapers
Quantitative Determination of Multiple Ingredients in Topical Formulation by Gas Chromatography
CPLAdvantages of Excipient GMP Certification
NSF International, Pharmaceutical ServicesHECHT Sampling Solutions for High-Quality Pharmaceuticals
HECHTEUDRA GMP CBD
CBDepotModern Pharmacovigilance and Regulatory Affairs in Pharmaceutical Applications
Pharmabide Pharmaceutical ServicesCritical Contamination Control Specialists
DycemThe Biggest Threats to Pharmaceutical Companies
ResolverCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Nexus Pharmaceuticals’ Sterile Injectable Manufacturing Facility, Wisconsin
Nexus Pharmaceuticals, a healthcare company based in the US, plans to build a sterile injectable manufacturing facility in Kenosha County, Wisconsin, US.
Fujifilm’s Cell Culture Media Manufacturing Facility, Netherlands
Sartorius’ Biopharmaceutical Manufacturing Facility Expansion, Puerto Rico
Phillips-Medisize Pharmaceutical Manufacturing Facility, Wisconsin
Tergus Pharma’s Commercial Manufacturing Facility, North Carolina
Clinical Trials
Sumitomo Dainippon publishes positive results of schizophrenia drug
Japanese pharma company Sumitomo Dainippon has announced its drug Lonasen (blonanserin) has achieved its primary endpoint in a Phase III trial of 150 adolescents with...
FDA approves Alexion’s Soliris as first treatment for CNS disease NMOSD
BMS’ Opdivo fails to reach primary endpoint in HCC
Dassault to enhance clinical tech with $5.8bn Medidata acquisition
Pembrolizumab trumps chemotherapy in recurrent head and neck cancer
Design
USPTO reverses decision regarding interfering CRISPR patents
The Patient Trial and Appeal Board (PTAB) of the US Patent and Trademark Office (USPTO) has changed its stance regarding an interference between ten patent...
Dassault to enhance clinical tech with $5.8bn Medidata acquisition
ProAmpac updates child-resistant pouch product line
Drug Development
Sumitomo Dainippon publishes positive results of schizophrenia drug
Japanese pharma company Sumitomo Dainippon has announced its drug Lonasen (blonanserin) has achieved its primary endpoint in a Phase III trial of 150 adolescents with...
Gilead gets licences to three antiviral programmes from Novartis
Boehringer forms alliance with Bridge Biotherapeutics for IPF drug
Mallinckrodt partners with Silence Therapeutics for RNAi drugs
Researchers develop ‘Trojan horse’ chemo drug delivery system
Market Data
Oklahoma seeks $17bn from J&J for opioid crisis
Lawyers for the US state of Oklahoma have argued that Johnson & Johnson (J&J) should be held responsible for driving opioid epidemic in the country...
Amgen and Novartis discontinue Alzheimer’s drug development programme
Eisai opens dementia-focused research facility in US
Reckitt to resolve Indivior’s opioid probe with $1.4bn settlement
Sandoz launches epinephrine injection amid shortage in US
Technology
Researchers develop ‘Trojan horse’ chemo drug delivery system
Northwestern University researchers have developed a drug delivery system that can disguise chemotherapy drugs as fat, meaning that tumours readily consume them, the drugs are...
Researchers develop genomic barcode to track immune cells
Recursion secures funds to support AI-based drug discovery
Merck and Skyhawk Therapeutics sign collaboration agreement
CRISPR study offers hope for potential HIV cure
Go Top